Toby and Aurélien, a magical moment! Stay tuned…

Behind the scene with Aurélien Alderweireldt 1⚽️1🧬 Toby Alderweireld UZA #RareDiseaseDay

A message from Toby Alderweireld 1⚽️1🧬 #RareDiseaseDay Toby Alderweireld UZA

Teamwork is everything, both in soccer and in research! Join our match against Rare Diseases, and let's score the winning goal together. 1 goal, 1 gene, and 1 donation can make a world of difference! With Toby Alderweireld support UZA and 101 Genomes 1⚽️1 🧬#RareDiseaseDay

Alderweireld en Alderweireldt scoren samen met UZA in strijd tegen zeldzaam ziekte syndroom van Marfan  vrtnws.be/p.VLWGlAl1E

Health data sharing and medicines access in peril from unreconciled conflicts ⁦EU One Health⁩ #EHDS #prices #research #pharmaceuticals

#CJUE: Concentration Illumina - GRAIL - l’#AG Emiliou propose d’annuler l’arrêt du #TribunalUE et les décisions de la European Commission concernant la demande de renvoi 👉 curia.europa.eu/jcms/jcms/Jo2_…

How AI is being used to accelerate clinical trials nature.com/articles/d4158…

The use of artificial intelligence (AI) in health care has seen remarkable growth in the past 5 years. A new Review from The Lancet Digital Health examines how AI could improve care management, clinical decision-making efficiency, and further research areas 👉 hubs.li/Q02v0wl50

Announcing AlphaFold 3: our state-of-the-art AI model for predicting the structure and interactions of all life’s molecules. 🧬 Here’s how we built it with Isomorphic Labs and what it means for biology. 🧵 dpmd.ai/3URDiNo

👇A must-see website for #aorticdisease adepts! 👏💪 Arturo Evangelista ! 🙏 for continuing to share your valuable knowledge! aortahub.com/en/ #AortaEd

La voie de signalisation PIK3CA joue un rôle clé dans le développement des glomérulonéphrites prolifératives (ex: atteinte rénale du lupus) et pourrait être une cible thérapeutique prometteuse. ➡️Comment une maladie rare permet de mieux comprendre une pathologie commune 🍾🎉🥳

Join us in Antwerp for the European Society of Cardiology Cardio Genomics Conference 2024! Abstract submission now open Antoine Bondue Lia Crotti esc365.escardio.org/event/1652?utm…

Today begins a new chapter for GRAIL as an independent, publicly traded company. We will be listed under $GRAL on Nasdaq as of the market open June 25. Learn more: bit.ly/3RG7HMo

Excited for our papers out in nature today! Please read this excellent thread by Patrick Hsu. Incredible teamwork was required for all this work to come together. Especially thankful to my co-lead Matt Durrant, and our collaborators at University of Tokyo hnisimasu and Masa#H

#ECJ annuls the #EUGeneralCourt’s judgment and the decisions by which the European Commission accepted requests to evaluate the merger project between Illumina et Grail 👉 curia.europa.eu/jcms/jcms/Jo2_…

1st y law student could predict things would go south. Illumina/Grail entailed the EC affirming competence to review mergers w/o jurisdiction under EU or national law. Make believe competition policy meets antitrust under the rule of law.

We’re presenting AlphaProteo: an AI system for designing novel proteins that bind more successfully to target molecules. 🧬 It could help scientists better understand how biological systems function, save time in research, advance drug design and more. 🧵 dpmd.ai/3XuMqbX

Mario Draghi calls on the EU to deregulate in order to foster innovation and help tech companies thrive. 🇪🇺🫡

Rivers are also causing flooding in #Vienna, #Austria. People are locked in their homes and subway services have been suspended. The situation is precarious, as can be seen in the photos.